Weight Loss Study
We are looking for adults living with obesity who do not have diabetes to take part in a clinical research study testing a new weekly injection for weight loss.
18+
About 84 weeks (about 1 year and 8 months)
About 22 visits
$91 per in-person visit; $46 per virtual visit; plus mileage, parking, meals, and travel reimbursement as applicable
About This Study
This study is testing an investigational weekly injection to see if it helps people living with obesity lose weight. It will be compared to an approved weight-loss medicine called semaglutide (Wegovy®) and a placebo (an injection with no active ingredient). Researchers want to learn how well the study drug works and whether it is safe.
If you join, you will be in the study for about 1 year and 8 months (about 84 weeks). You will have about 22 visits — some in person and some online (virtual). You will give yourself a weekly injection and will receive nutritional counseling and lifestyle support throughout the study. Blood and urine tests will be done at certain visits to check your health.
Taking part is completely voluntary. You can stop at any time without it affecting your regular medical care. There is no cost to you for study-related visits, tests, or the study drug.
You May Qualify If You
- Are 18 years of age or older
- Have a body mass index (BMI) of 35 or higher
- Do not have a diagnosis of diabetes (Type 1 or Type 2)
- Have tried at least one diet or exercise effort to lose weight in the last 6 months without success
- Have not used semaglutide, tirzepatide, or similar weight-loss injections in the last 3 months
- Have not had weight-loss surgery (such as gastric bypass)
- Are willing to give yourself a weekly injection and attend scheduled study visits
Interested in This Study?
Contact us to learn more and see if you qualify.